Donald G. Payan

2006

In 2006, Donald G. Payan earned a total compensation of $1.6M as Executive Vice President, President of Discovery and Research at Rigel Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$130,350
Option Awards$1,117,285
Salary$395,000
Other$2,315
Total$1,644,950

Payan received $1.1M in option awards, accounting for 68% of the total pay in 2006.

Payan also received $130.4K in non-equity incentive plan, $395K in salary and $2.3K in other compensation.

Rankings

In 2006, Donald G. Payan's compensation ranked 2,084th out of 7,022 executives tracked by ExecPay. In other words, Payan earned more than 70.3% of executives.

ClassificationRankingPercentile
All
2,084
out of 7,022
70th
Division
Manufacturing
646
out of 2,413
73rd
Major group
Chemicals And Allied Products
122
out of 673
82nd
Industry group
Drugs
70
out of 518
87th
Industry
Pharmaceutical Preparations
58
out of 355
84th
Source: SEC filing on April 15, 2009.

Payan's colleagues

We found five more compensation records of executives who worked with Donald G. Payan at Rigel Pharmaceuticals in 2006.

2006

James Gower

Rigel Pharmaceuticals

Chief Executive Officer

2006

Raul Rodriguez

Rigel Pharmaceuticals

Chief Operating Officer

2006

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2006

James Welch

Rigel Pharmaceuticals

Chief Financial Officer

2006

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

In-depth

You may also like